Indication
Prophylaxis of transplant rejection in adult kidney or liver allograft recipients. Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Tacforius 0,5 MG Capsulas Duras de Liberacion Prolongada EfgSpain · 0,5112 mgMarketed
- Tacforius 1 MG Capsulas Duras de Liberacion Prolongada EfgSpain · 1,0224 mgMarketed
- Tacforius 3 MG Capsulas Duras de Liberacion Prolongada EfgSpain · 3,0672 mgMarketed
- Tacforius 5 MG Capsulas Duras de Liberacion Prolongada EfgSpain · 5,112 mgMarketed